AlzeCure Pharma AB (publ) (STO:ALZCUR)
Sweden flag Sweden · Delayed Price · Currency is SEK
8.08
+0.14 (1.76%)
Sep 2, 2026, 5:29 PM CET

AlzeCure Pharma AB Ratios and Metrics

Millions SEK. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
1,095230102193257225
Market Cap Growth
167.64%126.34%-47.41%-24.88%14.39%-34.33%
Enterprise Value
1,08317362156220162
Last Close Price
7.941.750.962.443.254.49

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Forward PE
-7.337.332.35--
PB Ratio
11.986.983.908.124.256.82
P/TBV Ratio
11.986.993.908.134.256.82
P/FCF Ratio
---63.16--
P/OCF Ratio
---63.16--

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/FCF Ratio
---50.91--

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.020.120.19---
Net Debt / Equity Ratio
-0.13-1.41-1.02-1.22-0.42-1.27
Net Debt / EBITDA Ratio
-0.361.000.760.770.460.54
Net Debt / FCF Ratio
0.221.340.77-9.520.260.59
Quick Ratio
0.702.283.493.722.603.42
Current Ratio
4.112.333.553.842.663.49
Return on Equity (ROE)
62.86%-161.56%-141.83%-88.22%-120.35%-108.23%
Return on Assets (ROA)
27.25%-61.00%-63.14%-46.61%-60.70%-59.75%
Return on Capital Employed (ROCE)
32.40%-135.20%-121.20%-161.30%-93.50%-237.00%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
2.81%-20.73%-34.81%-19.25%-21.88%-34.62%
FCF Yield
-4.79%-15.05%-33.83%1.58%-38.87%-31.46%
Buyback Yield / Dilution
-28.89%-30.26%-24.26%-30.17%-26.30%-